EU leaders faced with surge of COVID-19 infections, vaccine issues
Brussels: European Union leaders are meeting Thursday to look for ways of ramping up COVID-19 vaccinations across the 27-nation region amid a shortage of doses, spikes in new cases, a feud with the United Kingdom and internal quarrels.
The Coronavirus pandemic once again prevented the leaders from meeting in person, reflecting the poor epidemiological situation in the EU.
The spread of more contagious variants of the virus has pushed hospitals in some countries to their limit, and combined with the lack of vaccines available in Europe, has led several EU members to impose strict lockdown measures over the Easter period.
Less than 5 per cent of the EU's 450 million residents have been fully vaccinated against COVID-19.
Ahead of Thursday's summit, the bloc's executive arm proposed strengthening export controls for Coronavirus shots.
Even if the move is detrimental to non-EU nations, the European Commission's goal is to force vaccine manufacturers, especially AstraZeneca, to deliver the doses agreed to in their contracts. The commission also wants to make sure a principle of export reciprocity is enforced with countries that are producing vaccines or the raw materials needed for them.
The mechanism has been divisive, according to various European diplomats who spoke before the summit. While some countries see it as an instrument of last resort that should not undermine the EU's reputation as an open trading bloc, others said it is a crucial tool to guarantee doses and vaccine ingredients reach the bloc.
Some countries refuse to export. So we need to introduce reciprocity criteria if we want to be able to keep our vaccination goal for the summer," said one diplomat, referring tot he EU's aim of having 70 per cent of the adult population vaccinated by that season.
Stricter control of exports could have an impact on Britain, whose speedy vaccination rollout after it formally withdrew from EU has been eyed with envy by many European nations.
The latest figures show that 45 per cent of British residents have had at least one vaccine shot, compared to less than 14 per cent for the EU. The EU's contract disputes with British-Swedish company AstraZeneca deepened the post-Brexit tensions. However, the EU and the U.K. pledged this week to increase cooperation and fight Europe's third wave of infections together.
